R&D Systems Inc. Tocris Bioscience Boston Biochem

Cannabinoid Receptors

Cannabinoid receptors are currently classified into three groups: central (CB1), peripheral (CB2) and GPR55, all of which are G-protein-coupled.

Cannabinoid Receptor Target Files

Related Categories

CB1 receptors are primarily located at central and peripheral nerve terminals. CB2 receptors are predominantly expressed in non-neuronal tissues, particularly immune cells, where they modulate cytokine release and cell migration. Recent reports have suggested that CB2 receptors may also be expressed in the CNS. GPR55 receptors are non-CB1/CB2 receptors that exhibit affinity for endogenous, plant and synthetic cannabinoids. Endogenous ligands for cannabinoid receptors have been discovered, including anandamide and 2-arachidonylglycerol.

Receptor Subtype CB1 CB2 GPR55
Transduction Mechanism ↓Adenylyl Cyclase (Gi/o), ↓ N- and P/Q-type Ca2+ currents, ↑ Kir and A-types K+ currents ↓ Adenylyl Cyclase (Gi/o) Activation of Rho family GTPases
Primary Distribution CNS: hippocampus, basal ganglia, cerebellum, cortex, globus pallidus, substantia nigra, pars reticulata Spleen, tonsils, immune cells CNS: caudate and putamen
Tissue Function Modulation of neurotransmitter release Suppression of immune cell function Pain signaling, control of vascular tone, inflammation

Key Compounds Ki Values (nM) at CB1 Ki Values (nM) at CB2
Endogenous Agonists Anandamide (1339)
2-Arachidonylglycerol (1298)
NADA (1568)
Noladin ether (1411)
61-543
58.3-472
2501
21.2
279-1940
145-1400
12001
> 3000
Key CB1 Agonists ACEA (1319)
ACPA (1318)
(R)-(+)-Methanandamide (1121)
1.4
2.2
17.9-28.3
> 2000
715
815-868
Key CB2 Agonists CB 65 (2663)
GP 1a (2764)
GP 2a (2678)
GW 405833 (2374)*
JWH 015 (1341)
JWH 133 (1343)
L-759,656 (2434)
L-759,633 (2433)
> 1000
363
900
4772
383
677
4888
1043
3.3
0.037
7.6
3.92
13.8
3.4
11.8
6.4
Non-selective Agonists CP 55,940 (0949)
HU 210 (0966)
O-2545 (2680)
WIN 55,212-2 (1038)
Bay 59-3074 (2500)
Δ9-Tetrahydrocannabinol (2741)
0.5-5.0
0.06-0.73
1.5
5.05
1.89-123
48.3
5.05
0.69-2.8
0.17-0.52
0.32
3.13
0.28-16.2
45.5
3.13
Key CB1 Antagonists/
Inverse Agonists
AM 251 (1117)
AM 281 (1115)
LY 320135 (2387)
7.49
12
141
2290
4200
14900
Key CB2 Antagonists/
Inverse Agonists
AM 630 (1120) 5152 31.2

*partial agonist

Quick Order

Find multiple products by catalog number

divider line

Pain Research Product Guide

Pain Research Guide

Highlights over 280 products for Pain research. Request copy or view PDF today.

divider line

Cannabinoid Review

Cannabinoid Receptor Ligands Review

Written by Roger Pertwee, an expert. Request a copy or view PDF today.

divider line

7-TM Receptor Signaling

Written by T. Kenakin et al

7-TM Poster

'Seven Transmembrane Receptor Signaling' highlights the multiple behaviors of 7-TMs including G-protein-dependent and -independent signaling as well as the concept of collateral efficacy

divider line

Therapeutic Strategies in Schizophrenia

Written by J. Lieberman

Schizophrenia Poster

'Schizophrenia - Emerging Targets and Therapeutic Strategies' provides a summary of the targets and pathways representing the most promising strategies to pursue for novel drug development.

divider line

Peripheral Sensitization

Written by Grant D. Nicol and Michael R. Vasko

Pain Poster

A summary of the excitatory and inhibitory signaling pathways involved in modulation of peripheral sensitization. Request a copy or view PDF today.

divider line

New Product Guide

NPG

Highlights over 130 new products added in the second half of 2013. Request a copy or view PDF today.

divider line

Twitter Updates

Follow @Tocris on Twitter

Follow us on Twitter!

Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.